Vivid Technology : Appendix 3Y - C Macek

Appendix 3Y

Change of Director's Interest Notice

Appendix 3Y

Rule 3.19A.2

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01	Amended 01/01/11
Name of entity	VIVID TECHNOLOGY LTD
ABN	60 120 710 625

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Charles Macek
Date of last notice	7 May 2018

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct/Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Kathmandu Investments Pty. Ltd. As Trustee For Excalibur National Private Super Fund (of which Mr Macek is a beneficiary)
Date of change	1 February 2019
No. of securities held prior to change	Kathmandu Investments Pty. Ltd. As Trustee For Excalibur National Private Super Fund: 4,000,000 fully paid ordinary shares Charles Macek: 1,500,000 unlisted options exercisable at 12.5 cents expiring 12 December 2019
Class	Fully paid ordinary shares
Number acquired	1,500,000
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$45,000.00

+ See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y

Change of Director's Interest Notice

No. of securities held after change	Kathmandu Investments Pty. Ltd. As Trustee For Excalibur National Private Super Fund: 4,000,000 fully paid ordinary shares. Charles Macek: 1,500,000 fully paid ordinary shares. Charles Macek: 1,500,000 unlisted options exercisable at 12.5 cents expiring 12 December 2019.
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Participation in Equity Placement

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

+ See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y

Change of Director's Interest Notice

Part 3 - +Closed period

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

+ See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3